Using and Choosing a Nephrostomy Tube after Percutaneous Nephrolithotomy for Large or Complex Stone Disease: A Treatment Strategy

2005 ◽  
Vol 19 (3) ◽  
pp. 348-352 ◽  
Author(s):  
Samuel C. Kim ◽  
William W. Tinmouth ◽  
Ramsay L. Kuo ◽  
Ryan F. Paterson ◽  
James E. Lingeman
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Treatment Strategy ◽  
Stone Disease ◽  
Nephrostomy Tube

scholarly journals Percutaneous nephrolithotomy with or without nephrostomy tube

2018 ◽  
Vol 11 (2) ◽  
pp. 189
Author(s):  
Mohammed Aulad Hossain ◽  
S. M. Yunus Ali ◽  
Mohammad Saiful Islam ◽  
Mohammad Jahangir Alam ◽  
Mollah Md. Abu Sayed ◽  
...  
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Renal Stone ◽  
Renal Stones ◽  
Stone Disease ◽  
Nephrostomy Tube ◽  
Visual Analogue Pain ◽  
Significant Difference ◽  
Group A ◽  
The Mean ◽  
Group B

<p class="Abstract">The study has been designed to compare the outcome of percutaneous nephrolithotomy with (Group A) or without nephrostomy tube (Group B) for the management of renal stone disease. JJ stents were given to all cases of both groups. Comparison of outcome between groups shows that urinary leakage time was significantly longer in Group B than that in Group A (24.0 ± 6.2 vs 7.3 ± 3.9 hours;  p&lt;0.001). Visual analogue pain score was also significantly high in Group B than in Group A (4.7 ± 0.8 vs 2.4 ± 0.5; p&lt;0.035). Patients in Group B stayed in hospital on an average 4 days, while the Group A patients stayed in hospital on an average 2.5 days (p&lt;0.029). The mean hemoglobin decrease in 24 hours in Group B and in Group A (0.5 ± 0.4 and 0.5 ± 0.4 respectively) did not show any significant difference (p&lt;0.895). In conclusion, percutaneous nephrolithotomy without nephrostomy tube can be practiced in the management of selective cases of renal stones diseases.</p>

Nephrostomy Tube after Percutaneous Nephrolithotomy: Large-Bore or Pigtail Catheter?

2000 ◽  
Vol 14 (9) ◽  
pp. 735-738 ◽  
Author(s):  
PANKAJ N. MAHESHWARI ◽  
MUKUND G. ANDANKAR ◽  
MANISH BANSAL
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Pigtail Catheter ◽  
Nephrostomy Tube

scholarly journals Intravenous misplacement of nephrostomy tube following percutaneous nephrolithotomy: Three new cases and review of seven cases in the literature

2014 ◽  
Vol 40 (5) ◽  
pp. 690-696 ◽  
Author(s):  
Xiao-Feng Chen ◽  
Shan-Qun Chen ◽  
Liang-Yu Xu ◽  
Ye Gong ◽  
Zhuang-Fei Chen ◽  
...  
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Nephrostomy Tube

Tubeless Percutaneous Nephrolithotomy with Hemostatic Plug Using Surgiflo® versus Standard Percutaneous Nephrolithotomy using a Nephrostomy Tube: A Prospective Randomized Controlled Study

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Hisham Mohamed Fathey Elshawaf ◽  
Mohamed Ismail Shabayek ◽  
Mohamed Ahmed Saleh Ahmed
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Intraoperative Complications ◽  
Demographic Data ◽  
Renal Stones ◽  
Controlled Study ◽  
P Value ◽  
Nephrostomy Tube ◽  
Gelatin Matrix ◽  
Significant Difference ◽  
Tubeless Pcnl

Abstract Background Percutaneous Nephrolithotomy (PCNL) is the preferred technique for treating large renal stones (over 2cm in diameter). It involves keyhole surgery performed through a small skin incision overlying the kidney. Objectives Our study aimed at evaluating the safety and efficacy of local hemostatic sealant (surgiflo®) use in tubeless PCNL to enhance postoperative outcomes of PCNL. Patients and Methods We randomized our patients into two groups, Group A nephrostomy tube was used as standard PCNL, and at group B tubeless PCNL was done followed by injection of the local hemostatic flowable gelatin matrix (surgiflo®) under fluoroscopic guidance in the prone position Results There was no statistically significant difference between two groups regarding demographic data age, sex and BMI (P- value 0.280, 0.736 and 0.440 respectively), stone site and size (P- value 0.525 and 0.533 respectively), operative time (P- value 0.855), intraoperative complications as blood loss and pelvicalyceal perforation, (P- value 0.92 and P- value 0.83 respectively), postoperative complication as fever, haematuria and UTI (P- value 1.000, 0,113 and 1.000 respectivly), and Hb drop (P- value 0.735). Conclusion Tubeless PCNL with hemostatic sealant use is associated with less pain, no leakage from nephrostomy tract, less narcotic agent use, and a shorter hospital stay.

Nephrostomy tube-free percutaneous nephrolithotomy for patients with large stones and staghorn stones

Urology ◽  
2006 ◽  
Vol 67 (1) ◽  
pp. 30-34 ◽  
Author(s):  
Yeong-Chin Jou ◽  
Ming-Chin Cheng ◽  
Chang-Te Lin ◽  
Pi-Che Chen ◽  
Jang-Huang Shen
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Nephrostomy Tube ◽  
Staghorn Stones

Medical therapy (dissolution therapy)

2017 ◽  
Author(s):  
Ben Turney ◽  
John Reynard
Keyword(s):  
Uric Acid ◽  
Medical Therapy ◽  
Percutaneous Nephrolithotomy ◽  
Oral Treatment ◽  
Stone Disease ◽  
Stone Composition ◽  
Large Stone ◽  
Oral Agents ◽  
Long Time ◽  
Cystine Stones

Medical therapy of stone disease aims to prevent stones or dissolve existing stones. Dissolution therapy aims to dissolve stones through administration of oral agents to by direct chemolysis through renal irrigation. Since dissolution therapy may take weeks to achieve an effect, it is usually used as an adjunct to endourological treatment. Urate stones are most amenable to dissolution therapy. Stones containing any calcium have a lower chance of successful dissolution. Providing stone composition is known, irrigating chemolysis is an option for patients with large stone burdens who are unsuitable for percutaneous nephrolithotomy (PCNL). Both uric acid and cystine stones can be treated with irrigating solutions of trihydroxymethyl-aminomethan with pH 8.5–9.0, though it takes a long time to dissolve stones and oral treatment is preferred.

Sign in / Sign up

Export Citation Format

Share Document